Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 102862
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.102862
Table 1 Comparison of clinical data, n (%)
Characteristic
Anastomotic leakage group (n = 49)
No anastomotic leakage group (n = 385)
Statistic
P value
Age0.960.32821
    < 60173 (44.9)18 (37.5)
    ≥ 60212 (55.1)30 (62.5)
Gender3.660.05621
    Male220 (57.1)35 (71.4)
    Female165 (42.9)14 (28.6)
BMI0.26232
    < 18.511 (2.9)4 (8.2)
    18.5-24169 (43.9)22 (44.9)
    24-28159 (41.3)19 (38.8)
    ≥ 2846 (11.9)4 (8.2)
Smoking0.870.35221
    No268 (69.8)31 (63.3)
    Yes116 (30.2)18 (36.7)
Drinking1.610.20421
    No308 (80.2)43 (87.8)
    Yes76 (19.8)6 (12.2)
History of hypertension2.030.15521
    No295 (76.6)33 (67.3)
    Yes90 (23.4)16 (32.7)
Cardiac insufficiency0.13332
    No371 (96.4)45 (91.8)
    Yes14 (3.6)4 (8.2)
History of diabetes3.970.04621
    No330 (85.7)47 (95.9)
    Yes55 (14.3)2 (4.1)
History of abdominal surgery0.480.48721
    No289 (75.1)39 (79.6)
    Yes96 (24.9)10 (20.4)
ASA0.46232
    1-2369 (95.8)46 (93.9)
    3-416 (4.2)3 (6.1)
Bowel obstruction0.31332
    No366 (95.1)45 (91.8)
    Yes19 (4.9)4 (8.2)
Black stool0.040.83921
    No163 (42.3)20 (40.8)
    Yes222 (57.7)29 (59.2)
Differentiated degree> 0.99932
    Poorly33 (8.6)4 (8.2)
    Moderately317 (82.3)41 (83.7)
    Well35 (9.1)4 (8.2)
Nerve invasion1.010.31421
    Negative320 (83.3)38 (77.6)
    Positive64 (16.7)11 (22.4)
Intravascular tumor emboli0.000.95521
    Negative313 (81.3)40 (81.6)
    Positive72 (18.7)9 (18.4)
T stage0.46432
    T120 (5.2)2 (4.2)
    T259 (15.3)4 (8.3)
    T3281 (73.0)37 (77.1)
    T425 (6.5)5 (10.4)
N stage0.58532
    N0224 (58.2)31 (63.3)
    N1101 (26.2)9 (18.4)
    N256 (14.5)9 (18.4)
    N34 (1.0)0 (0.0)
Tumor stage0.190.65921
    1-2223 (57.9)30 (61.2)
    3-4162 (42.1)19 (38.8)
Table 2 Haematological and serological indicators, n (%)
Indicators
Anastomotic leakage
group (n = 49)1
No anastomotic leakage group (n = 385)1
Statistic
P value
WBC6.00 (5.18, 7.29)6.39 (4.63, 7.87)9333.000.9052
Hb135 (120, 148)120 (103, 138)12738.00< 0.0012
Plt244 (199, 292)225 (195, 302)9945.000.5362
LYM1.83 (1.49, 2.23)1.34 (1.13, 1.64)14667.50< 0.0012
NE3.59 (2.88, 4.35)4.05 (2.84, 5.76)7957.500.0752
MONO0.44 (0.34, 0.55)0.51 (0.39, 0.64)7374.000.0132
OPNI50.5 (47.4, 53.2)42.5 (39.3, 45.6)16750.50< 0.0012
NLR1.94 (1.46, 2.59)3.20 (2.03, 4.22)4799.00< 0.0012
PLR131 (101, 173)179 (123, 251)5934.50< 0.0012
CEA (%)2.1230.1453
    Normal238 (61.8)25 (51.0)
    High147 (38.2)24 (49.0)
CA199 (%)0.0020.9653
    Normal284 (73.8)36 (73.5)
    High101 (26.2)13 (26.5)
Table 3 Analysis of risk factors for anastomotic leakage
Variables

Univariate
Multivariate
β
SE
Z
P value
OR (95%CI)
β
SE
Z
P value
OR (95%CI)
Hb-0.0210.006-3.634< 0.0010.980 (0.969-0.991)0.0010.0080.1270.8991.001 (0.986-1.016)
LYM-2.2510.400-5.625< 0.0010.105 (0.048-0.231)0.4550.7430.6130.5400.634 (0.148-2.719)
MONO1.8820.7022.6810.0076.567 (1.659-25.995)1.1091.1190.9910.3223.031 (0.338-27.160)
NE0.2710.0763.556< 0.0011.312 (1.129-1.523)0.1500.2120.7100.4780.860 (0.568-1.303)
OPNI-0.3540.045-7.781< 0.0010.702 (0.642-0.768)-0.3500.048-7.227< 0.0010.705 (0.641-0.775)
NLR0.6090.1145.337< 0.0011.838 (1.470-2.298)0.4880.1473.317< 0.0011.628 (1.221-2.172)
PLR0.0080.0024.348< 0.0011.008 (1.004-1.012)-0.0060.003-2.0260.0430.994 (0.989-0.999)